Christopher James analyst

Currently, out of the existing stock ratings of Christopher James - 2 which are a Hold (11.11%), 16 which are a Buy (88.89%)

Christopher James

Work Performance Price Targets & Ratings Chart

Analyst Christopher James was covering the Healthcare sector with 32 price targets and ratings displayed on 5 stocks. Previously, Christopher James worked at LADENBURG, B. RILEY.

Christopher James's average stock forecast success ratio is 53.33% with an average time for price targets to be met of 104.6 days.

Most recent stock forecast was given on ACHN, at 12-Sep-2017.

Wall Street Analyst Christopher James

Analyst best performing recommendations are on ZFGN.
The best stock recommendation documented was for ZFGN at 10/16/2015. The price target of $16 was fulfilled within 39 days with a profit of $5.64 (54.44%) receiving and performance score of 13.96.

Average potential price target upside

ACHN ALNY Alnylam Pharmaceuticals CORT Corcept Therapeutics TRVN Trevena ZFGN

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$1.82 (1011.11%)

5

4 years 7 months 1 days ago

2/3 (66.67%)

$-1.08 (-9.01%)

528

Hold

4

5 years 9 months 26 days ago

4/4 (100%)

$-2.13 (-24.58%)

106

Buy

5

$4.82 (2677.78%)

6

5 years 11 months 23 days ago

0/4 (0%)

$5.96 (74.71%)

Buy

10

6 years 2 months 22 days ago

0/2 (0%)

$6.87 (118.02%)

Hold

4

$3.82 (2122.22%)

5

6 years 2 months 23 days ago

6/7 (85.71%)

$1.8 (31.38%)

49

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Christopher James?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart